Effect of omalizumab on peripheral blood eosinophilia in allergic asthma
- 1 February 2010
- journal article
- Published by Elsevier in Respiratory Medicine
- Vol. 104 (2) , 188-196
- https://doi.org/10.1016/j.rmed.2009.09.011
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Asthma cases attributable to atopy: Results from the Third National Health and Nutrition Examination SurveyJournal of Allergy and Clinical Immunology, 2007
- Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukastThorax, 2005
- The rise of the phoenix: the expanding role of the eosinophil in health and diseaseAllergy, 2004
- Omalizumab rapidly decreases nasal allergic response and FcεRI on basophils☆Journal of Allergy and Clinical Immunology, 2004
- Omalizumab treatment downregulates dendritic cell FcεRI expressionJournal of Allergy and Clinical Immunology, 2003
- Omalizumab is effective in the long-term control of severe allergic asthmaAnnals of Allergy, Asthma & Immunology, 2003
- Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthmaJournal of Allergy and Clinical Immunology, 2001
- Blood eosinophils from atopic donors express messenger RNA for the α, β, and γ subunits of the high-affinity IgE receptor (FcϵRI) and intracellular, but not cell surface, α subunit proteinJournal of Allergy and Clinical Immunology, 2000
- IMMUNOLOGIC BASIS OF ANTIGEN-INDUCED AIRWAY HYPERRESPONSIVENESSAnnual Review of Immunology, 1999
- Association of Asthma with Serum IgE Levels and Skin-Test Reactivity to AllergensNew England Journal of Medicine, 1989